Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11965713rdf:typepubmed:Citationlld:pubmed
pubmed-article:11965713lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:11965713lifeskim:mentionsumls-concept:C0476089lld:lifeskim
pubmed-article:11965713lifeskim:mentionsumls-concept:C0019932lld:lifeskim
pubmed-article:11965713lifeskim:mentionsumls-concept:C0205225lld:lifeskim
pubmed-article:11965713pubmed:issue1lld:pubmed
pubmed-article:11965713pubmed:dateCreated2002-4-22lld:pubmed
pubmed-article:11965713pubmed:abstractTextSix cases of primary treated endometrial cancer are included in this research work. Five of these women ended with tumour regression and 2 with pregnancies and deliveries of children. All of the women are still alive without having disease with mean follow-up period of 36.5 months (from 16 to 80 months). We consider that this is very promising method of treatment to offer y conservative treatment with high level of survival and possibility for having y child. Diagnostic and therapeutic data for the patients who are with early endometrial cancer and wish to have y child are analyised in this study. Four of the women were treated with GnRh-analogs-Zoladex and 2 with progestins-high doses.lld:pubmed
pubmed-article:11965713pubmed:languagebullld:pubmed
pubmed-article:11965713pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11965713pubmed:citationSubsetIMlld:pubmed
pubmed-article:11965713pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11965713pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11965713pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11965713pubmed:statusMEDLINElld:pubmed
pubmed-article:11965713pubmed:issn0324-0959lld:pubmed
pubmed-article:11965713pubmed:authorpubmed-author:IvanovVVlld:pubmed
pubmed-article:11965713pubmed:authorpubmed-author:MilevAAlld:pubmed
pubmed-article:11965713pubmed:authorpubmed-author:IvanovSSlld:pubmed
pubmed-article:11965713pubmed:authorpubmed-author:K?rlovTTlld:pubmed
pubmed-article:11965713pubmed:authorpubmed-author:KulanderSSlld:pubmed
pubmed-article:11965713pubmed:issnTypePrintlld:pubmed
pubmed-article:11965713pubmed:volume38lld:pubmed
pubmed-article:11965713pubmed:ownerNLMlld:pubmed
pubmed-article:11965713pubmed:authorsCompleteYlld:pubmed
pubmed-article:11965713pubmed:pagination20-3lld:pubmed
pubmed-article:11965713pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:11965713pubmed:meshHeadingpubmed-meshheading:11965713...lld:pubmed
pubmed-article:11965713pubmed:meshHeadingpubmed-meshheading:11965713...lld:pubmed
pubmed-article:11965713pubmed:meshHeadingpubmed-meshheading:11965713...lld:pubmed
pubmed-article:11965713pubmed:meshHeadingpubmed-meshheading:11965713...lld:pubmed
pubmed-article:11965713pubmed:meshHeadingpubmed-meshheading:11965713...lld:pubmed
pubmed-article:11965713pubmed:meshHeadingpubmed-meshheading:11965713...lld:pubmed
pubmed-article:11965713pubmed:meshHeadingpubmed-meshheading:11965713...lld:pubmed
pubmed-article:11965713pubmed:meshHeadingpubmed-meshheading:11965713...lld:pubmed
pubmed-article:11965713pubmed:meshHeadingpubmed-meshheading:11965713...lld:pubmed
pubmed-article:11965713pubmed:meshHeadingpubmed-meshheading:11965713...lld:pubmed
pubmed-article:11965713pubmed:meshHeadingpubmed-meshheading:11965713...lld:pubmed
pubmed-article:11965713pubmed:year1999lld:pubmed
pubmed-article:11965713pubmed:articleTitle[Primary hormone treatment of early endometrial cancer].lld:pubmed
pubmed-article:11965713pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:11965713pubmed:publicationTypeEnglish Abstractlld:pubmed
pubmed-article:11965713pubmed:publicationTypeCase Reportslld:pubmed